Simpson, S H <br/><br/>
Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  Jul 2015 
 - 899-906 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-5491 
<br/><br/><label>Standard No.: </label>10.1111/dme.12692  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Canada--epidemiology<br/>Cardiovascular Diseases--complications<br/>Combined Modality Therapy--economics<br/>Cost-Benefit Analysis<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Angiopathies--economics<br/>Diabetic Cardiomyopathies--economics<br/>Drug Monitoring--economics<br/>Female<br/>Follow-Up Studies<br/>Health Care Costs<br/>Humans<br/>Male<br/>Middle Aged<br/>Patient Acceptance of Health Care<br/>Patient Care Team--economics<br/>Pharmacists--economics<br/>Primary Health Care<br/>Risk Factors